tiprankstipranks
Advertisement
Advertisement

IP Group returns to profit as Pfizer deal and tech exits lift NAV and fund buybacks

Story Highlights
  • IP Group’s NAV and profits rebounded in 2025, powered by Metsera-related royalty value and strong portfolio fundraising.
  • Cash from exits, including Hinge Health and Monolith, funded major buybacks while the group deepened its UK early-stage investment reach.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
IP Group returns to profit as Pfizer deal and tech exits lift NAV and fund buybacks

Meet Samuel – Your Personal Investing Prophet

IP Group plc ( (GB:IPO) ) has shared an announcement.

IP Group plc reported a return to profitability in 2025 as net asset value per share rose 13% to 110.4p, driven largely by the recognition of £128.2m in discounted future royalty and milestone income following Pfizer’s acquisition of obesity-drug developer Metsera. The group now has meaningful economic exposure to Pfizer’s GLP-1 obesity franchise, while its portfolio benefited from positive Phase 2b results for PF’3944, strong capital raising by investee companies and a growing pipeline of AI-related technologies.

The company generated £68.1m of cash from exits, including the NYSE flotation and full disposal of digital musculoskeletal clinic Hinge Health and the sale of Monolith AI to CoreWeave Inc., supporting a £75m share buyback that retired 9% of its share capital. IP Group maintained a robust balance sheet with £211m in gross cash, continued to build third-party funds under management via Parkwalk and a new Northern Universities Venture Fund, and expanded its role in early-stage UK investing through a new mandate with Aberdeen, underscoring its position as a leading university IP investor and its focus on long-term shareholder value.

The most recent analyst rating on (GB:IPO) stock is a Hold with a £56.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.

Spark’s Take on IPO Stock

According to Spark, TipRanks’ AI Analyst, IPO is a Neutral.

The score is held back primarily by weak financial performance (recent losses and negative cash flow), with limited valuation support from a negative P/E. Mixed technicals suggest no strong momentum tailwind, while the latest earnings call provides a moderate offset via improved cash proceeds, NAV stabilization, and management confidence in exit targets despite portfolio-specific setbacks.

To see Spark’s full report on IPO stock, click here.

More about IP Group plc

IP Group plc is a UK-listed investment company that backs breakthrough science and technology businesses, with a particular focus on university spin-outs and innovation-led ventures. The group partners closely with leading research institutions and provides long-term capital to scale companies in areas such as life sciences, deep tech and AI-enabling technologies.

Average Trading Volume: 2,839,267

Technical Sentiment Signal: Strong Sell

Current Market Cap: £435.1M

For a thorough assessment of IPO stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1